1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Travel Vaccines Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Travel Vaccines Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Growing incidence of infectious diseases drives the market growth
- 5.1.2 Rising International Travel Accelerates Demand for Travel Vaccines which is expected to Favor the Market Growth
5.2 Market Opportunities
- 5.2.1 Rising investment in Research & Development (R&D)for Travel Vaccine to Provide Lucrative Market Opportunities
5.3 Future Trends
- 5.3.1 Digitalization for travel vaccines are likely to remain key trends in the market.
5.4 Impact of Drivers and Restraints
6. North America Travel Vaccines Market Regional Analysis
6.1 North America Travel Vaccines Market Overview
6.2 North America Travel Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 North America Travel Vaccines Market Forecast Analysis
7. North America Travel Vaccines Market Analysis – by Product
7.1 Hepatitis A
- 7.1.1 Overview
- 7.1.2 Hepatitis A: North America Travel Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Hepatitis B
- 7.2.1 Overview
- 7.2.2 Hepatitis B: North America Travel Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Meningococcal Vaccines
- 7.3.1 Overview
- 7.3.2 Meningococcal Vaccines: North America Travel Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Travel Vaccines Market Analysis – by Application
8.1 Domestic Travel and Outbound Travel
- 8.1.1 Overview
- 8.1.2 Domestic Travel and Outbound Travel : North America Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Travel Vaccines Market – North America Analysis
9.1 North America
- 9.1.1 North America Travel Vaccines Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.1.1.1 North America Travel Vaccines Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 US: North America Travel Vaccines Market Breakdown, by Product
- 9.1.1.1.2 US: North America Travel Vaccines Market Breakdown, by Application
- 9.1.1.2 Canada:
North America Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Canada: North America Travel Vaccines Market Breakdown, by Product
- 9.1.1.2.2 Canada: North America Travel Vaccines Market Breakdown, by Application
- 9.1.1.3 Mexico :
North America Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 Mexico : North America Travel Vaccines Market Breakdown, by Product
- 9.1.1.3.2 Mexico : North America Travel Vaccines Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Travel Vaccines Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Dynavax Technologies
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Emergent BioSolutions Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 GlaxoSmithKline plc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Merck & Co., Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Novartis AG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Pfizer Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Sanofi
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Valneva SE.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Travel Vaccines Market
